What is Arcus Biosciences's PP&E (net)?

Arcus Biosciences (RCUS) reported PP&E (net) of $38M in Q1 2026.

How has Arcus Biosciences's PP&E (net) changed year-over-year?

Arcus Biosciences's PP&E (net) decreased by 17.4% year-over-year, from $46M to $38M.

What is the long-term trend for Arcus Biosciences's PP&E (net)?

Over 5 years (2020 to 2025), Arcus Biosciences's PP&E (net) has grown at a 29.9% compound annual growth rate (CAGR), from $10.81M to $40M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Arcus Biosciences RCUS PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

Merck & Co.MRK

$25.43B+2.6%

AbbVieABBV

$5.69B+8.6%

ImmunomeIMNM

$17.08M+55.9%

IDEAYA Biosciences, Inc.IDYA

$8.63M-2.7%

IncyteINCY

$720.17M-5.9%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's PP&E (net)?: Arcus Biosciences (RCUS) reported PP&E (net) of $38M in Q1 2026.
How has Arcus Biosciences's PP&E (net) changed year-over-year?: Arcus Biosciences's PP&E (net) decreased by 17.4% year-over-year, from $46M to $38M.
What is the long-term trend for Arcus Biosciences's PP&E (net)?: Over 5 years (2020 to 2025), Arcus Biosciences's PP&E (net) has grown at a 29.9% compound annual growth rate (CAGR), from $10.81M to $40M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.